Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiani Hu

Showing results (271-280 of 284) with videos related to

Pageof 29
Sort By:
PLOS Global Public Health|September 11, 2025
Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 acquisition in Africa: A cohort studyNonhlanhla N Mkhize, Shuying Sue Li, Jiani Hu, et al.
Journal of Global Health|June 23, 2023
Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global regionShelly Karuna, Jorge A Gallardo-Cartagena, Deborah Theodore, et al.
JCI Insight|August 1, 2024
Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119Spyros A Kalams, Barbara K Felber, James I Mullins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective StudyInes Vaz-Luis, Romualdo Barroso-Sousa, Antonio Di Meglio, et al.
The Oncologist|September 2, 2021
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast CancerRomualdo Barroso-Sousa, Ines Vaz-Luis, Antonio Di Meglio, et al.
JCI Insight|September 22, 2022
Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19Daniel J Schuster, Shelly Karuna, Caroline Brackett, et al.
Communications Medicine|April 24, 2025
Distinct immune responses in people living with HIV following SARS-CoV-2 recoveryDieter Mielke, Shuying Sue Li, Daniel J Schuster, et al.
Nature Communications|September 22, 2021
Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancerTanya E Keenan, Jennifer L Guerriero, Romualdo Barroso-Sousa, et al.
Iscience|April 22, 2026
Coordinated immune response distinguishes duration of SARS-CoV-2 viral particle shedding in humansDaniel J Schuster, Shuying S Li, Dieter Mielke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 MonotherapyXue Bai, Jiani Hu, Allison Betof Warner, et al.
Pageof 29

Showing results (271-280 of 284) with videos related to

Sort By:
Pageof 29
PLOS Global Public Health|September 11, 2025
Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 acquisition in Africa: A cohort studyNonhlanhla N Mkhize, Shuying Sue Li, Jiani Hu, et al.
Journal of Global Health|June 23, 2023
Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global regionShelly Karuna, Jorge A Gallardo-Cartagena, Deborah Theodore, et al.
JCI Insight|August 1, 2024
Focusing HIV-1 Gag T cell responses to highly conserved regions by DNA vaccination in HVTN 119Spyros A Kalams, Barbara K Felber, James I Mullins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 25, 2020
Avoiding Peg-Filgrastim Prophylaxis During the Paclitaxel Portion of the Dose-Dense Doxorubicin-Cyclophosphamide and Paclitaxel Regimen: A Prospective StudyInes Vaz-Luis, Romualdo Barroso-Sousa, Antonio Di Meglio, et al.
The Oncologist|September 2, 2021
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast CancerRomualdo Barroso-Sousa, Ines Vaz-Luis, Antonio Di Meglio, et al.
JCI Insight|September 22, 2022
Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19Daniel J Schuster, Shelly Karuna, Caroline Brackett, et al.
Communications Medicine|April 24, 2025
Distinct immune responses in people living with HIV following SARS-CoV-2 recoveryDieter Mielke, Shuying Sue Li, Daniel J Schuster, et al.
Nature Communications|September 22, 2021
Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancerTanya E Keenan, Jennifer L Guerriero, Romualdo Barroso-Sousa, et al.
Iscience|April 22, 2026
Coordinated immune response distinguishes duration of SARS-CoV-2 viral particle shedding in humansDaniel J Schuster, Shuying S Li, Dieter Mielke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 MonotherapyXue Bai, Jiani Hu, Allison Betof Warner, et al.
Pageof 29